{"filing":{"accession_number":"0001213900-26-093244","cik":"0001873875","ticker":"IXHL","company_name":"Incannex Healthcare Inc.","form":"8-K","filing_date":"2026-08-25","report_date":"2026-08-25","primary_document":"ea0303140-8k_incannex.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1873875/000121390026093244/ea0303140-8k_incannex.htm"},"events":[{"id":29327,"run_id":26845,"accession_number":"0001213900-26-093244","anchor_item_number":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"The filing discloses a clinical development milestone: the first patient dosed in the DReAMzz Phase 2 dose-optimization study of IHL-42X for obstructive sleep apnea. This represents material operational progress for a clinical-stage biopharmaceutical company, building on prior positive Phase 2 RePOSA results and FDA Fast Track designation. While not a specific named event type, this is clearly an operational/clinical milestone that would affect a reasonable investor's assessment of the company's drug development progress and timeline.","company_name":"Incannex Healthcare Inc.","ticker":"IXHL","filing_date":"2026-08-25","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":31574,"accession_number":"0001213900-26-093244","item_number":null,"item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"The filing discloses a clinical development milestone: the first patient dosed in the DReAMzz Phase 2 dose-optimization study of IHL-42X for obstructive sleep apnea. This represents material operational progress for a clinical-stage biopharmaceutical company, building on prior positive Phase 2 RePOSA results and FDA Fast Track designation. While not a specific named event type, this is clearly an operational/clinical milestone that would affect a reasonable investor's assessment of the company's drug development progress and timeline.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-25T11:32:41.848332+00:00","company_name":"Incannex Healthcare Inc.","ticker":"IXHL","filing_date":"2026-08-25"}]}